Cargando…
Rewiring cancer cell death to enhance oncolytic viro-immunotherapy
Oncolytic viruses are novel immunotherapeutic agents that appear to mediate potent antineoplastic effects in both preclinical and clinical settings. Recent studies demonstrate that manipulating the mechanisms whereby cancer cells die in the course of oncolytic virotherapy has potential to boost anti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912054/ https://www.ncbi.nlm.nih.gov/pubmed/24498567 http://dx.doi.org/10.4161/onci.27138 |
| _version_ | 1782302039827546112 |
|---|---|
| author | Workenhe, Samuel T Mossman, Karen L |
| author_facet | Workenhe, Samuel T Mossman, Karen L |
| author_sort | Workenhe, Samuel T |
| collection | PubMed |
| description | Oncolytic viruses are novel immunotherapeutic agents that appear to mediate potent antineoplastic effects in both preclinical and clinical settings. Recent studies demonstrate that manipulating the mechanisms whereby cancer cells die in the course of oncolytic virotherapy has potential to boost anticancer immune responses. |
| format | Online Article Text |
| id | pubmed-3912054 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39120542014-02-04 Rewiring cancer cell death to enhance oncolytic viro-immunotherapy Workenhe, Samuel T Mossman, Karen L Oncoimmunology Author's View Oncolytic viruses are novel immunotherapeutic agents that appear to mediate potent antineoplastic effects in both preclinical and clinical settings. Recent studies demonstrate that manipulating the mechanisms whereby cancer cells die in the course of oncolytic virotherapy has potential to boost anticancer immune responses. Landes Bioscience 2013-12-01 2013-12-09 /pmc/articles/PMC3912054/ /pubmed/24498567 http://dx.doi.org/10.4161/onci.27138 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | Author's View Workenhe, Samuel T Mossman, Karen L Rewiring cancer cell death to enhance oncolytic viro-immunotherapy |
| title | Rewiring cancer cell death to enhance oncolytic viro-immunotherapy |
| title_full | Rewiring cancer cell death to enhance oncolytic viro-immunotherapy |
| title_fullStr | Rewiring cancer cell death to enhance oncolytic viro-immunotherapy |
| title_full_unstemmed | Rewiring cancer cell death to enhance oncolytic viro-immunotherapy |
| title_short | Rewiring cancer cell death to enhance oncolytic viro-immunotherapy |
| title_sort | rewiring cancer cell death to enhance oncolytic viro-immunotherapy |
| topic | Author's View |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912054/ https://www.ncbi.nlm.nih.gov/pubmed/24498567 http://dx.doi.org/10.4161/onci.27138 |
| work_keys_str_mv | AT workenhesamuelt rewiringcancercelldeathtoenhanceoncolyticviroimmunotherapy AT mossmankarenl rewiringcancercelldeathtoenhanceoncolyticviroimmunotherapy |